default author photo

Ronald van Vollenhoven

University of Amsterdam - Department of Rheumatology and Clinical Immunology

Amsterdam

Netherlands

SCHOLARLY PAPERS

5

DOWNLOADS

515

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Antibody Development after SARS-CoV-2 Vaccinations in Elderly Patients with Autoimmune Diseases: Data From a Prospective Controlled Cohort Study

Number of pages: 20 Posted: 28 Jun 2021
University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Sanquin Research - Department of Immunopathology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC, Vrije Universiteit - Department of Neurology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Department of Medical Microbiology and Infection Control, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, VU University Amsterdam, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Sanquin Research - Department of Immunopathology and University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade
Downloads 219 (348,255)

Abstract:

Loading...

2.

Certolizumab pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-Reported Outcomes of the NORD-STAR Trial

Number of pages: 26 Posted: 07 Oct 2025
Karolinska Institutet, University of Helsinki - Helsinki University Hospital, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Copenhagen - Department of Clinical Medicine, Diakonhjemmet Hospital, University of Copenhagen, University of Gothenburg - Department of Rheumatology and Inflammation Research, Diakonhjemmet Hospital, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Landspitali University Hospital, Karolinska Institutet, University of Southern Denmark, University of Eastern Finland, University of Iceland, University of Copenhagen, Karolinska University Hospital, Sahlgrenska University Hospital, University of Eastern Finland, Lund University, Karolinska Institutet, Diakonhjemmet Hospital, Helsinki University Hospital, Silkeborg Regional Hospital - Diagnostic Centre, Lund University, Uppsala University - Uppsala University Hospital, University of Southern Denmark, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Falun Hospital, Ålesund Hospital, University of Bergen - Haukeland University Hospital, Odense University Hospital, Örebro University Hospital, Västmanland´s Hospital, Linkoping University, Karolinska Institutet, Aalborg University, Odense University Hospital, Trondheim University Hospital, Aarhus University, University Hospital of North Norway - Department of Rheumatology, University of Oslo - Department of Research Support for Clinical Trials, Diakonhjemmet Hospital and Diakonhjemmet Hospital
Downloads 92 (730,864)

Abstract:

Loading...

Arthritis, Rheumatoid arthritis, Patient reported outcome, Pain, Fatigue, Biologic drug, TNF, Il-6, Abatacept, Remission

3.

Antibody Development and Disease Severity of Covid-19 in Non-Immunized Patients with Rheumatic Immune-Mediated Inflammatory Diseases: Data from a Prospective Cohort Study

Number of pages: 21 Posted: 13 Oct 2021
University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Medical Microbiology and Infection Control, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, VU University Amsterdam - Amsterdam Rheumatology and immunology Center, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, Sanquin Research - Department of Immunopathology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Sanquin Research - Department of Immunopathology and University of Amsterdam - Amsterdam Rheumatology and Immunology Centre
Downloads 81 (796,622)

Abstract:

Loading...

4.

SARS-CoV-2 Delta Breakthrough Infections in Vaccinated Patients with Immune-Mediated Inflammatory Diseases Using Immunosuppressants – Data from Two Controlled Prospective Cohort Studies

Number of pages: 26 Posted: 16 Mar 2022
University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC - Department of Neurology and Neurophysiology, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Amsterdam UMC - Department of Neurology and Neurophysiology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Location Reade, Amsterdam UMC - Department of Neurology and Neurophysiology, Sanquin Research - Department of Immunopathology, Amsterdam UMC, Vrije Universiteit - Department of Neurology, VU University Amsterdam, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Department of Neurology, University of Amsterdam - Department of Neurology, affiliation not provided to SSRN, University of Amsterdam - Department of Gastroenterology and Hepatology, University of Amsterdam - University Medical Center, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Dermatology, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Internal Medicine, VU University Medical Center - Amsterdam Rheumatology and Immunology Center, University of Amsterdam - Department of Clinical Immunology and Rheumatology, University of Amsterdam - Department of Clinical Immunology and Rheumatology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - University Medical Center Groningen (UMCG), University of Groningen - Department of Rheumatology and Clinical Immunology, University of Groningen - Department of Dermatology, Leiden University - Department of Neurology, Leiden University - Department of Neurology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Rheumatology, Leiden University - Department of Nephrology, Maastricht University - Division of Nephrology and Clinical Immunology, Department of Immunology, Maastricht UMC+, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Erasmus University Rotterdam (EUR) - Department of Neurology, Radboud University Nijmegen - Radboud University Medical Center, Erasmus University Rotterdam (EUR) - Department of Dermatology, Utrecht University - Brain Center Rudolf Magnus, Utrecht University - University Medical Center (Utrecht), University of Amsterdam - Department of Medical Microbiology and Infection Control, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, affiliation not provided to SSRN, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research - Department of Immunopathology, Sanquin Research, Sanquin Research, University of Amsterdam - University Medical Center, Sanquin Research - Department of Immunopathology, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pediatric Immunology, Rheumatology and Infectious Disease, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre and Amsterdam UMC - Department of Neurology and Neurophysiology
Downloads 71 (867,774)

Abstract:

Loading...

Breakthrough infectionsCOVID-19SARS-CoV-2Immune mediated inflammatory diseasesAnti-CD20 therapyImmunosuppressantsEpidemiologyIncidenceDisease severityHumoral immunity

5.

Acylcarnitine Enrichment as a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic Fingerprint

Number of pages: 29 Posted: 12 May 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Amsterdam - Department of Rheumatology and Clinical Immunology, Karolinska Institutet, Landspitali University Hospital, Diakonhjemmet Hospital, University of Helsinki - Helsinki University Hospital, University of Iceland, University of Southern Denmark, University of Eastern Finland, Karolinska Institutet, University of Copenhagen - Department of Clinical Medicine, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Copenhagen, Diakonhjemmet Hospital, University of Gothenburg - Department of Rheumatology and Inflammation Research, University of Gothenburg - Department of Molecular and Clinical Medicine, University of California, San Diego (UCSD) - Department of Cellular & Molecular Medicine and affiliation not provided to SSRN
Downloads 52 (1,041,696)

Abstract:

Loading...

rheumatoid arthritis, Fibroblast-like synoviocytes, metabolomics, acylcarnitines